| David M Denton, MD | |
|
1151 Hospital Way, Building F, Pocatello, ID 83201-5091 | |
| (208) 232-1443 | |
| (208) 239-3434 |
| Full Name | David M Denton |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Adolescent Medicine |
| Location | 1151 Hospital Way, Pocatello, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558363341 | NPI | - | NPPES |
| 805197600 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080A0000X | Pediatrics - Adolescent Medicine | M-7586 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David M Denton, MD 1151 Hospital Way, Building F, Pocatello, ID 83201-5091 Ph: (208) 232-1443 | David M Denton, MD 1151 Hospital Way, Building F, Pocatello, ID 83201-5091 Ph: (208) 232-1443 |
News Archive
Use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer control outcomes, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.
Seattle Genetics, Inc. and Millennium The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive top-line results from a phase II clinical trial of single-agent brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30. The trial was conducted in 58 relapsed or refractory systemic anaplastic large cell lymphoma (ALCL) patients.
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing antibody to increase its binding affinity for the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The engineered antibody demonstrates high potency in neutralizing SARS-CoV-2 and preventing infection in animals.
Participating in an 8-week mindfulness meditation program appears to make measurable changes in brain regions associated with memory, sense of self, empathy and stress. In a study that will appear in the January 30 issue of Psychiatry Research: Neuroimaging, a team led by Massachusetts General Hospital researchers report the results of their study, the first to document meditation-produced changes over time in the brain's grey matter.
› Verified 3 days ago
Dr. Don E Mcinturff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1151 Hospital Way, Building F, Pocatello, ID 83201 Phone: 208-232-1443 Fax: 208-239-3434 | |
Christian Carter Yost, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 950 Hospital Way Ste A, Pocatello, ID 83201 Phone: 208-233-7337 Fax: 208-235-1839 | |
Dr. Roger W. Boe, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 405 W Whitman St, Pocatello, ID 83204 Phone: 208-233-6833 | |
Alison Marie Mcinturff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1151 Hospital Way Bldg F, Pocatello, ID 83201 Phone: 208-232-1443 | |
Andrea Lewis Swenson, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1110 Call Creek Dr Ste 7, Pocatello, ID 83201 Phone: 208-233-4660 Fax: 208-233-4262 | |
Dr. Matthew Ayers Murdoch, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1151 Hospital Way, Building F, Pocatello, ID 83201 Phone: 208-232-1443 Fax: 208-239-3434 | |
Dr. Gregory Daniel Kostur, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 500 S 11th Ave Ste 204, Pocatello, ID 83201 Phone: 208-232-3355 Fax: 855-230-7350 |